Bigul

Sanofi India Ltd - 500674 - Compliance - Compliance Certificate For The Period Ended September, 2019

Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the compliance certificate for the period 1st April 2019 to 30th September 2019.
16-10-2019
Bigul

Sanofi India Ltd - 500674 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 30Th September 2019.

Pursuant to Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith Certificate of M/s. Makarand M. Joshi & Co., Company Secretaries for the half year ended 30th September 2019.
16-10-2019
Bigul

Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates in lieu of the original share certificates reported lost/misplaced, details of which are enclosed.
16-10-2019
Bigul

Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are enclosed.
14-10-2019
Bigul

Nordisk and Sanofi log double-digit revenue growth in insulin pens

Around 6.98 million insulin pens were sold; it was 6.97 mn in the year-before period
09-10-2019

Location intelligence platform GeoIQ secures undisclosed funding from IP Venture

GeoIQ allows firms to make critical business decision based on location intelligence or data points derived from geospatial information.It already has a client base of over 25 companies and startups across retail and logistics including Sanofi, Eko Financial, Bounce, Curefit among others
09-10-2019
Bigul

Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed copies of the Postal Ballot Notice of the Company published today, in newspapers, Business Standard and Sakal.
01-10-2019
Bigul

Sanofi India Ltd - 500674 - Postal Ballot Notice

The Board of Directors at its meeting held on 10th September 2019 approved the Postal Ballot Notice for seeking approval of members of the Company on Resolution as set out in the said Notice. Please find enclosed copy of the Postal Ballot Notice together with the Explanatory Statement which is dispatched to the members of the Company today, whose names appear on the Register of Members / List of Beneficial Owners as on 20th September 2019.
30-09-2019
Bigul

Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates in lieu of the original share certificates reported lost/misplaced, details of which are enclosed.
25-09-2019
Bigul

Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are enclosed.
18-09-2019
Next Page
Close

Let's Open Free Demat Account